<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36613731</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>24</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">287</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24010287</ELocationID><Abstract><AbstractText>Although progressive wasting and weakness of respiratory muscles are the prominent hallmarks of Duchenne muscular dystrophy (DMD) and long-COVID (also referred as the post-acute sequelae of COVID-19 syndrome); however, the underlying mechanism(s) leading to respiratory failure in both conditions remain unclear. We put together the latest relevant literature to further understand the plausible mechanism(s) behind diaphragm malfunctioning in COVID-19 and DMD conditions. Previously, we have shown the role of matrix metalloproteinase-9 (MMP9) in skeletal muscle fibrosis via a substantial increase in the levels of tumor necrosis factor-&#x3b1; (TNF-&#x3b1;) employing a DMD mouse model that was crossed-bred with MMP9-knockout (MMP9-KO or MMP9<sup>-/-</sup>) strain. Interestingly, recent observations from clinical studies show a robust increase in neopterin (NPT) levels during COVID-19 which is often observed in patients having DMD. What seems to be common in both (DMD and COVID-19) is the involvement of neopterin (NPT). We know that NPT is generated by activated white blood cells (WBCs) especially the M1 macrophages in response to inducible nitric oxide synthase (iNOS), tetrahydrobiopterin (BH4), and tetrahydrofolate (FH4) pathways, i.e., folate one-carbon metabolism (FOCM) in conjunction with epigenetics underpinning as an immune surveillance protection. Studies from our laboratory, and others researching DMD and the genetically engineered humanized (hACE2) mice that were administered with the spike protein (SP) of SARS-CoV-2 revealed an increase in the levels of NPT, TNF-&#x3b1;, HDAC, IL-1&#x3b2;, CD147, and MMP9 in the lung tissue of the animals that were subsequently accompanied by fibrosis of the diaphragm depicting a decreased oscillation phenotype. Therefore, it is of interest to understand how regulatory processes such as epigenetics involvement affect DNMT, HDAC, MTHFS, and iNOS that help generate NPT in the long-COVID patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tyagi</LastName><ForeName>Suresh C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushpakumar</LastName><ForeName>Sathnur</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sen</LastName><ForeName>Utpal</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mokshagundam</LastName><ForeName>Sri Prakash L</ForeName><Initials>SPL</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism and Diabetes and Robley Rex VA Medical Center, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Dinesh K</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0001-5254-4067</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saad</LastName><ForeName>Mohamed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep Disorders Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Mahavir</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2415-3314</Identifier><AffiliationInfo><Affiliation>Department of Physiology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HL-74185, HL-139047, DK116591 and AR-71789</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.35</RegistryNumber><NameOfSubstance UI="D020780">Matrix Metalloproteinase 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>670-65-5</RegistryNumber><NameOfSubstance UI="D019798">Neopterin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020780" MajorTopicYN="N">Matrix Metalloproteinase 9</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018101" MajorTopicYN="N">Mice, Inbred mdx</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019798" MajorTopicYN="N">Neopterin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020388" MajorTopicYN="Y">Muscular Dystrophy, Duchenne</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus infection</Keyword><Keyword MajorTopicYN="N">disease management</Keyword><Keyword MajorTopicYN="N">lung dysfunction</Keyword><Keyword MajorTopicYN="N">multiorgan damage</Keyword><Keyword MajorTopicYN="N">neopterin</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest, financial or otherwise.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36613731</ArticleId><ArticleId IdType="pmc">PMC9820572</ArticleId><ArticleId IdType="doi">10.3390/ijms24010287</ArticleId><ArticleId IdType="pii">ijms24010287</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Omar I.M., Weaver J.S., Samet J.D., Serhal A.M., Mar W.A., Taljanovic M.S. Musculoskeletal Manifestations of COVID-19: Currently Described Clinical Symptoms and Multimodality Imaging Findings. Radiogr. A Rev. Publ. Radiol. Soc. N. Am. Inc. 2022;42:1415&#x2013;1432. doi: 10.1148/rg.220036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.220036</ArticleId><ArticleId IdType="pmc">PMC9341171</ArticleId><ArticleId IdType="pubmed">35867593</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., Pushpakumar S., Bard N., Zheng Y., Homme R.P., Mokshagundam S.P.L., Tyagi S.C. Simulation of COVID-19 symptoms in a genetically engineered mouse model: Implications for the long haulers. Mol. Cell. Biochem. 2022:1&#x2013;17. doi: 10.1007/s11010-022-04487-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-022-04487-0</ArticleId><ArticleId IdType="pmc">PMC9214689</ArticleId><ArticleId IdType="pubmed">35731343</ArticleId></ArticleIdList></Reference><Reference><Citation>Homme R.P., George A.K., Singh M., Smolenkova I., Zheng Y., Pushpakumar S., Tyagi S.C. Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury. Int. J. Mol. Sci. 2021;22:13546. doi: 10.3390/ijms222413546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222413546</ArticleId><ArticleId IdType="pmc">PMC8706694</ArticleId><ArticleId IdType="pubmed">34948342</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi S.C., Singh M. Multi-organ damage by COVID-19: Congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage. Mol. Cell. Biochem. 2021;476:1891&#x2013;1895. doi: 10.1007/s11010-021-04054-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-021-04054-z</ArticleId><ArticleId IdType="pmc">PMC7822399</ArticleId><ArticleId IdType="pubmed">33483858</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine H., Prais D., Aharoni S., Nevo Y., Katz J., Rahmani E., Goldberg L., Scheuerman O. COVID-19 in advanced Duchenne/Becker muscular dystrophy patients. Neuromuscul. Disord. 2021;31:607&#x2013;611. doi: 10.1016/j.nmd.2021.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2021.03.011</ArticleId><ArticleId IdType="pmc">PMC8021445</ArticleId><ArticleId IdType="pubmed">34053847</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamaga A.K., Alghamdi F., Alshaikh N., Altwaijri W., Bashiri F.A., Hundallah K., Abukhaled M., Muthaffar O.Y., Al-Mehmadi S., Jamaly T.A., et al. Consensus Statement on the Management of Duchenne Muscular Dystrophy in Saudi Arabia during the Coronavirus Disease 2019 Pandemic. Front. Pediatr. 2021;9:629549. doi: 10.3389/fped.2021.629549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.629549</ArticleId><ArticleId IdType="pmc">PMC7927788</ArticleId><ArticleId IdType="pubmed">33681102</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlivan R., Desikan M., Cruces F., Pietrusz A., Savvatis K. Clinical outcome of SARS-CoV-2 infection in 7 adults with Duchenne muscular dystrophy attending a specialist neuromuscular centre. Neuromuscul. Disord. 2021;31:603&#x2013;606. doi: 10.1016/j.nmd.2021.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2021.04.005</ArticleId><ArticleId IdType="pmc">PMC8076729</ArticleId><ArticleId IdType="pubmed">34049779</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerapandiyan A., Wagner K.R., Apkon S., McDonald C.M., Mathews K.D., Parsons J.A., Wong B.L., Eichinger K., Shieh P.B., Butterfield R.J., et al. The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic. Muscle Nerve. 2020;62:41&#x2013;45. doi: 10.1002/mus.26902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26902</ArticleId><ArticleId IdType="pmc">PMC7264600</ArticleId><ArticleId IdType="pubmed">32329920</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiu E.M., Kornberg A.J. Duchenne muscular dystrophy. Neurol. India. 2008;56:236&#x2013;247. doi: 10.1111/jpc.12868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.12868</ArticleId><ArticleId IdType="pubmed">18974549</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan D., Goemans N., Takeda S., Mercuri E., Aartsma-Rus A. Duchenne muscular dystrophy. Nat. Rev. Dis. Primers. 2021;7:13. doi: 10.1038/s41572-021-00248-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00248-3</ArticleId><ArticleId IdType="pmc">PMC10557455</ArticleId><ArticleId IdType="pubmed">33602943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaslow J.A., Soslow J.H., Burnette W.B., Raucci F.J., Hills T.J., Ibach M.G., Hebblethwaite R.C., Arps K.M., Sokolow A.G. Improving Access and Guideline Adherence in Pulmonary Care in Patients with Duchenne Muscular Dystrophy. Respir. Care. 2022;67:347&#x2013;352. doi: 10.4187/respcare.09502.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.09502</ArticleId><ArticleId IdType="pmc">PMC8984916</ArticleId><ArticleId IdType="pubmed">34876494</ArticleId></ArticleIdList></Reference><Reference><Citation>McKim D.A., Cripe T.P., Cripe L.H. The effect of emerging molecular and genetic therapies on cardiopulmonary disease in Duchenne muscular dystrophy. Pediatric Pulmonol. 2021;56:729&#x2013;737. doi: 10.1002/ppul.25079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25079</ArticleId><ArticleId IdType="pubmed">33142052</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnkrant D.J., Carter J.C. Cardiopulmonary phenotypic variability and discordance in Duchenne muscular dystrophy: Implications for new therapies. Pediatric Pulmonol. 2021;56:738&#x2013;746. doi: 10.1002/ppul.25111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25111</ArticleId><ArticleId IdType="pubmed">33049122</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumura K., Shasby D.M., Campbell K.P. Purification of dystrophin-related protein (utrophin) from lung and its identification in pulmonary artery endothelial cells. FEBS Lett. 1993;326:289&#x2013;293. doi: 10.1016/0014-5793(93)81810-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(93)81810-M</ArticleId><ArticleId IdType="pubmed">8325382</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlenker E.H., Burbach J.A. Structure and function of the respiratory system of the dystrophic hamster. Lung. 1990;168:125&#x2013;136. doi: 10.1007/BF02719684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02719684</ArticleId><ArticleId IdType="pubmed">2114506</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Mittal A., Paul P.K., Kumar M., Srivastava D.S., Tyagi S.C., Kumar A. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: A potential role of MMP-9 in myopathy. J. Biol. Chem. 2009;284:4439&#x2013;4450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2640955</ArticleId><ArticleId IdType="pubmed">19074147</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahiya S., Givvimani S., Bhatnagar S., Qipshidze N., Tyagi S.C., Kumar A. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy. J. Immunol. (Baltim. Md. 1950) 2011;187:2723&#x2013;2731. doi: 10.4049/jimmunol.1101342.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1101342</ArticleId><ArticleId IdType="pmc">PMC3159792</ArticleId><ArticleId IdType="pubmed">21810612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovechkin A.V., Lominadze D., Sedoris K.C., Robinson T.W., Tyagi S.C., Roberts A.M. Lung ischemia-reperfusion injury: Implications of oxidative stress and platelet-arteriolar wall interactions. Arch. Physiol. Biochem. 2007;113:1&#x2013;12. doi: 10.1080/13813450601118976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13813450601118976</ArticleId><ArticleId IdType="pmc">PMC3182489</ArticleId><ArticleId IdType="pubmed">17522980</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovarelli M., Arnaboldi F., Zecchini S., Cornaghi L.B., Nava A., Sommariva M., Clementi E.G.I., Gagliano N. Characterisation of Progressive Skeletal Muscle Fibrosis in the Mdx Mouse Model of Duchenne Muscular Dystrophy: An In Vivo and In Vitro Study. Int. J. Mol. Sci. 2022;23:8735. doi: 10.3390/ijms23158735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158735</ArticleId><ArticleId IdType="pmc">PMC9369129</ArticleId><ArticleId IdType="pubmed">35955872</ArticleId></ArticleIdList></Reference><Reference><Citation>Rucklidge G.J., Milne G., McGaw B.A., Milne E., Robins S.P. Turnover rates of different collagen types measured by isotope ratio mass spectrometry. Biochim. Et. Biophys. Acta. 1992;1156:57&#x2013;61. doi: 10.1016/0304-4165(92)90095-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-4165(92)90095-C</ArticleId><ArticleId IdType="pubmed">1472539</ArticleId></ArticleIdList></Reference><Reference><Citation>Houweling P.J. The antioxidants neopterin/7,8-dihydroneopterin: Novel biomarker and muscle protectant in Duchenne muscular dystrophy. Exp. Physiol. 2018;103:939&#x2013;940. doi: 10.1113/EP087093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP087093</ArticleId><ArticleId IdType="pubmed">29786157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay A., Schmiechen A., Chamberlain C.M., Ervasti J.M., Lowe D.A. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function. Exp. Physiol. 2018;103:995&#x2013;1009. doi: 10.1113/EP087031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP087031</ArticleId><ArticleId IdType="pmc">PMC6026059</ArticleId><ArticleId IdType="pubmed">29791760</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauvin M., Larsen M., Quirant B., Quentric P., Dorgham K., Royer L., Vallet H., Guihot A., Combadi&#xe8;re B., Combadi&#xe8;re C., et al. Elevated Neopterin Levels Predict Fatal Outcome in SARS-CoV-2-Infected Patients. Front. Cell. Infect. Microbiol. 2021;11:709893. doi: 10.3389/fcimb.2021.709893.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.709893</ArticleId><ArticleId IdType="pmc">PMC8419218</ArticleId><ArticleId IdType="pubmed">34497777</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy H.M., Al-Gareeb A.I., Alzahrani K.J., Cruz-Martins N., Batiha G.E. The potential role of neopterin in COVID-19: A new perspective. Mol. Cell. Biochem. 2021;476:4161&#x2013;4166. doi: 10.1007/s11010-021-04232-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-021-04232-z</ArticleId><ArticleId IdType="pmc">PMC8317144</ArticleId><ArticleId IdType="pubmed">34319496</ArticleId></ArticleIdList></Reference><Reference><Citation>Consalvi S., Tucciarone L., Macr&#xec; E., De Bardi M., Picozza M., Salvatori I., Renzini A., Valente S., Mai A., Moresi V., et al. Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro-adipogenic progenitors. EMBO Rep. 2022;23:e54721. doi: 10.15252/embr.202254721.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202254721</ArticleId><ArticleId IdType="pmc">PMC9171680</ArticleId><ArticleId IdType="pubmed">35383427</ArticleId></ArticleIdList></Reference><Reference><Citation>Harr J.C., Schmid C.D., Mu&#xf1;oz-Jim&#xe9;nez C., Romero-Bueno R., Kalck V., Gonzalez-Sandoval A., Hauer M.H., Padeken J., Askjaer P., Mattout A., et al. Loss of an H3K9me anchor rescues laminopathy-linked changes in nuclear organization and muscle function in an Emery-Dreifuss muscular dystrophy model. Genes Dev. 2020;34:560&#x2013;579. doi: 10.1101/gad.332213.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.332213.119</ArticleId><ArticleId IdType="pmc">PMC7111258</ArticleId><ArticleId IdType="pubmed">32139421</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt C.A., Brown A.G.M., Dixit S., Farmer N., Natarajan A., Boyington J., Shi S., Lu Q., Cotton P. Perspectives: On Precision Nutrition Research in Heart, Lung, and Blood Diseases and Sleep Disorders. Adv. Nutr. (Bethesda Md.) 2022;13:1402&#x2013;1414. doi: 10.1093/advances/nmac053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmac053</ArticleId><ArticleId IdType="pmc">PMC9526828</ArticleId><ArticleId IdType="pubmed">35561742</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt M.J., Aru G.M., Hayden M.R., Moore C.K., Hoit B.D., Tyagi S.C. Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002;283:L239&#x2013;L245. doi: 10.1152/ajplung.00001.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00001.2002</ArticleId><ArticleId IdType="pubmed">12114184</ArticleId></ArticleIdList></Reference><Reference><Citation>Pushpakumar S., Ren L., Kundu S., Gamon A., Tyagi S.C., Sen U. Toll-like Receptor 4 Deficiency Reduces Oxidative Stress and Macrophage Mediated Inflammation in Hypertensive Kidney. Sci. Rep. 2017;7:6349. doi: 10.1038/s41598-017-06484-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06484-6</ArticleId><ArticleId IdType="pmc">PMC5526876</ArticleId><ArticleId IdType="pubmed">28743964</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeremic N., Weber G.J., Tyagi S.C. Ablation of toll-like receptor 4 mitigates cardiac mitochondrial dysfunction in hyperhomocysteinemia. Can. J. Physiol. Pharmacol. 2017;95:1369&#x2013;1375. doi: 10.1139/cjpp-2016-0744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2016-0744</ArticleId><ArticleId IdType="pubmed">28738166</ArticleId></ArticleIdList></Reference><Reference><Citation>Familtseva A., Jeremic N., Kunkel G.H., Tyagi S.C. Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia. Mol. Cell. Biochem. 2017;433:177&#x2013;194. doi: 10.1007/s11010-017-3026-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-017-3026-9</ArticleId><ArticleId IdType="pubmed">28386844</ArticleId></ArticleIdList></Reference><Reference><Citation>Familtseva A., Chaturvedi P., Kalani A., Jeremic N., Metreveli N., Kunkel G.H., Tyagi S.C. Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension. Am. J. Physiol. Cell Physiol. 2016;311:C596&#x2013;C606. doi: 10.1152/ajpcell.00088.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00088.2016</ArticleId><ArticleId IdType="pmc">PMC5129755</ArticleId><ArticleId IdType="pubmed">27488663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Chen L., Wang F., Zheng X., Yuan C., Niu Q., Li Z., Deng L., Zheng B., Li C., et al. Exogenous hydrogen sulfide prevents lipopolysaccharide-induced inflammation by blocking the TLR4/NF-&#x3ba;B pathway in MAC-T cells. Gene. 2019;710:114&#x2013;121. doi: 10.1016/j.gene.2019.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2019.05.033</ArticleId><ArticleId IdType="pubmed">31153885</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Tao J., Duan F., Li H., Tan H. HHcy Induces Pyroptosis and Atherosclerosis via the Lipid Raft-Mediated NOX-ROS-NLRP3 Inflammasome Pathway in apoE-/- Mice. Cells. 2022;11:2438. doi: 10.3390/cells11152438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11152438</ArticleId><ArticleId IdType="pmc">PMC9368640</ArticleId><ArticleId IdType="pubmed">35954287</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;ladeau C., Sandhu J.K. Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases. Int. J. Mol. Sci. 2021;22:6068. doi: 10.3390/ijms22116068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116068</ArticleId><ArticleId IdType="pmc">PMC8200055</ArticleId><ArticleId IdType="pubmed">34199845</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau Y.S., Zhao L., Zhang C., Li H., Han R. Genetic disruption of the inflammasome adaptor ASC has minimal impact on the pathogenesis of Duchenne muscular dystrophy in mdx mice. Life Sci. 2020;257:118069. doi: 10.1016/j.lfs.2020.118069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118069</ArticleId><ArticleId IdType="pmc">PMC7484256</ArticleId><ArticleId IdType="pubmed">32659370</ArticleId></ArticleIdList></Reference><Reference><Citation>Boursereau R., Abou-Samra M., Lecompte S., Noel L., Brichard S.M. Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy. BMC Biol. 2018;16:33. doi: 10.1186/s12915-018-0501-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-018-0501-z</ArticleId><ArticleId IdType="pmc">PMC5861675</ArticleId><ArticleId IdType="pubmed">29558930</ArticleId></ArticleIdList></Reference><Reference><Citation>He W.T., Wan H., Hu L., Chen P., Wang X., Huang Z., Yang Z.H., Zhong C.Q., Han J. Gasdermin D is an executor of pyroptosis and required for interleukin-1&#x3b2; secretion. Cell Res. 2015;25:1285&#x2013;1298. doi: 10.1038/cr.2015.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2015.139</ArticleId><ArticleId IdType="pmc">PMC4670995</ArticleId><ArticleId IdType="pubmed">26611636</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhang Z., Ruan J., Pan Y., Magupalli V.G., Wu H., Lieberman J. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153&#x2013;158. doi: 10.1038/nature18629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18629</ArticleId><ArticleId IdType="pmc">PMC5539988</ArticleId><ArticleId IdType="pubmed">27383986</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentil C., Le Guiner C., Falcone S., Hogrel J.Y., Peccate C., Lorain S., Benkhelifa-Ziyyat S., Guigand L., Montus M., Servais L., et al. Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy. Hum. Gene Ther. 2016;27:712&#x2013;726. doi: 10.1089/hum.2016.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2016.041</ArticleId><ArticleId IdType="pubmed">27279388</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano C., Mojumdar K., Liang F., Lemaire C., Li T., Richardson J., Divangahi M., Qureshi S., Petrof B.J. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Hum. Mol. Genet. 2015;24:2147&#x2013;2162. doi: 10.1093/hmg/ddu735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu735</ArticleId><ArticleId IdType="pmc">PMC4380065</ArticleId><ArticleId IdType="pubmed">25552658</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojumdar K., Giordano C., Lemaire C., Liang F., Divangahi M., Qureshi S.T., Petrof B.J. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy. J. Pathol. 2016;239:10&#x2013;22. doi: 10.1002/path.4689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4689</ArticleId><ArticleId IdType="pubmed">26800321</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva A.M., Guo X., Bartkuhn M., G&#xfc;nther S., K&#xfc;nne C., Smolka C., Atzberger A., G&#xe4;rtner U., Mamchaoui K., Bober E., et al. Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression. Nat. Commun. 2022;13:4184. doi: 10.1038/s41467-022-31798-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31798-z</ArticleId><ArticleId IdType="pmc">PMC9300598</ArticleId><ArticleId IdType="pubmed">35859073</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz T.I., Raucci F.J., Jr., Salloum F.N. Cardiovascular Disease in Duchenne Muscular Dystrophy: Overview and Insight Into Novel Therapeutic Targets. JACC. Basic Transl. Sci. 2022;7:608&#x2013;625. doi: 10.1016/j.jacbts.2021.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.11.004</ArticleId><ArticleId IdType="pmc">PMC9270569</ArticleId><ArticleId IdType="pubmed">35818510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C., Zhao Y., Ding X., Gao B. Hypoxic Training Ameliorates Skeletal Muscle Microcirculation Vascular Function in a Sirt3-Dependent Manner. Front. Physiol. 2022;13:921763. doi: 10.3389/fphys.2022.921763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.921763</ArticleId><ArticleId IdType="pmc">PMC9340254</ArticleId><ArticleId IdType="pubmed">35923237</ArticleId></ArticleIdList></Reference><Reference><Citation>Machin D.R., Auduong Y., Gogulamudi V.R., Liu Y., Islam M.T., Lesniewski L.A., Donato A.J. Lifelong SIRT-1 overexpression attenuates large artery stiffening with advancing age. Aging. 2020;12:11314&#x2013;11324. doi: 10.18632/aging.103322.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103322</ArticleId><ArticleId IdType="pmc">PMC7343505</ArticleId><ArticleId IdType="pubmed">32564006</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharyya S., Sharma S.M., Cheng A.S., Ladner K.J., He W., Kline W., Wang H., Ostrowski M.C., Huang T.H., Guttridge D.C. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: Implications in duchenne muscular dystrophy. PLoS ONE. 2010;5:e12479. doi: 10.1371/journal.pone.0012479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012479</ArticleId><ArticleId IdType="pmc">PMC2930001</ArticleId><ArticleId IdType="pubmed">20814569</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpatti J.R., Ghahramani-Seno M.M., Mansat M., Sabha N., Sarikaya E., Goodman S.J., Chater-Diehl E., Celik A., Pannia E., Froment C., et al. X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition. Acta Neuropathol. 2022;144:537&#x2013;563. doi: 10.1007/s00401-022-02468-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02468-7</ArticleId><ArticleId IdType="pmc">PMC9381459</ArticleId><ArticleId IdType="pubmed">35844027</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehorst E., Odria R., Cap&#xf3; J., N&#xfa;&#xf1;ez-Manch&#xf3;n J., Arbex A., Almendrote M., Linares-Pardo I., Natera-de Benito D., Saez V., Nascimento A., et al. An Integrative Analysis of DNA Methylation Pattern in Myotonic Dystrophy Type 1 Samples Reveals a Distinct DNA Methylation Profile between Tissues and a Novel Muscle-Associated Epigenetic Dysregulation. Biomedicines. 2022;10:1372. doi: 10.3390/biomedicines10061372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10061372</ArticleId><ArticleId IdType="pmc">PMC9220235</ArticleId><ArticleId IdType="pubmed">35740394</ArticleId></ArticleIdList></Reference><Reference><Citation>Baribault C., Ehrlich K.C., Ponnaluri V.K.C., Pradhan S., Lacey M., Ehrlich M. Developmentally linked human DNA hypermethylation is associated with down-modulation, repression, and upregulation of transcription. Epigenetics. 2018;13:275&#x2013;289. doi: 10.1080/15592294.2018.1445900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2018.1445900</ArticleId><ArticleId IdType="pmc">PMC5997157</ArticleId><ArticleId IdType="pubmed">29498561</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., George A.K., Eyob W., Homme R.P., Stansic D., Tyagi S.C. High-methionine diet in skeletal muscle remodeling: Epigenetic mechanism of homocysteine-mediated growth retardation. Can. J. Physiol. Pharmacol. 2021;99:56&#x2013;63. doi: 10.1139/cjpp-2020-0093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2020-0093</ArticleId><ArticleId IdType="pubmed">32799662</ArticleId></ArticleIdList></Reference><Reference><Citation>Herminghaus A., Kozlov A.V., Szab&#xf3; A., Hantos Z., Gylstorff S., Kuebart A., Aghapour M., Wissuwa B., Walles T., Walles H., et al. A Barrier to Defend-Models of Pulmonary Barrier to Study Acute Inflammatory Diseases. Front. Immunol. 2022;13:895100. doi: 10.3389/fimmu.2022.895100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.895100</ArticleId><ArticleId IdType="pmc">PMC9300899</ArticleId><ArticleId IdType="pubmed">35874776</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinmann G.G., Croxton T.L., Aggarwal N.R., Twery M.J., Kiley J.P. A Perspective: Division of Lung Diseases at Fifty. Am. J. Respir. Crit. Care Med. 2019;200:1466&#x2013;1471. doi: 10.1164/rccm.201910-1999PP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201910-1999PP</ArticleId><ArticleId IdType="pmc">PMC6909826</ArticleId><ArticleId IdType="pubmed">31657967</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubuisson N., Versele R., Davis-L&#xf3;pez de Carrizosa M.A., Selvais C.M., Brichard S.M., Abou-Samra M. Walking down Skeletal Muscle Lane: From Inflammasome to Disease. Cells. 2021;10:3023. doi: 10.3390/cells10113023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10113023</ArticleId><ArticleId IdType="pmc">PMC8616386</ArticleId><ArticleId IdType="pubmed">34831246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Niu F., Chen J., Cao X., Liu Z., Bao X., Xu Y. Ghrelin improves muscle function in dystrophin-deficient mdx mice by inhibiting NLRP3 inflammasome activation. Life Sci. 2019;232:116654. doi: 10.1016/j.lfs.2019.116654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.116654</ArticleId><ArticleId IdType="pubmed">31306657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Junior E.S., Morandini A.C. Gasdermin: A new player to the inflammasome game. Biomed. J. 2017;40:313&#x2013;316. doi: 10.1016/j.bj.2017.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2017.10.002</ArticleId><ArticleId IdType="pmc">PMC6138612</ArticleId><ArticleId IdType="pubmed">29433834</ArticleId></ArticleIdList></Reference><Reference><Citation>On&#xf3;di Z., Ruppert M., Kucsera D., Sayour A.A., T&#xf3;th V.E., Koncsos G., Nov&#xe1;k J., Brenner G.B., Makkos A., Baranyai T., et al. AIM2-driven inflammasome activation in heart failure. Cardiovasc. Res. 2021;117:2639&#x2013;2651. doi: 10.1093/cvr/cvab202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab202</ArticleId><ArticleId IdType="pubmed">34117866</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Huang X., Li W., Qian G., Zhou B., Wang X. Carbon monoxide ameliorates LPS-induced acute lung injury via inhibition of alveolar macrophage pyroptosis. Exp. Anim. :2022. doi: 10.1538/expanim.22-0023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.22-0023</ArticleId><ArticleId IdType="pmc">PMC9978127</ArticleId><ArticleId IdType="pubmed">36184484</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Chiang Y.L., Lyssiotis C.A., Teater M.R., Hong J.Y., Shen H., Wang L., Hu J., Jing H., Chen Z., et al. Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis. Cancer Cell. 2019;35:916&#x2013;931.e9. doi: 10.1016/j.ccell.2019.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2019.05.002</ArticleId><ArticleId IdType="pmc">PMC7534582</ArticleId><ArticleId IdType="pubmed">31185214</ArticleId></ArticleIdList></Reference><Reference><Citation>Salo H.S., Laitinen T., Poso A., Jarho E., Lahtela-Kakkonen M. Identification of novel SIRT3 inhibitor scaffolds by virtual screening. Bioorg. Med. Chem. Lett. 2013;23:2990&#x2013;2995. doi: 10.1016/j.bmcl.2013.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2013.03.033</ArticleId><ArticleId IdType="pubmed">23562596</ArticleId></ArticleIdList></Reference><Reference><Citation>Troelsen K.S., B&#xe6;k M., Nielsen A.L., Madsen A.S., Rajabi N., Olsen C.A. Mitochondria-targeted inhibitors of the human SIRT3 lysine deacetylase. RSC Chem. Biol. 2021;2:627&#x2013;635. doi: 10.1039/D0CB00216J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0CB00216J</ArticleId><ArticleId IdType="pmc">PMC8341665</ArticleId><ArticleId IdType="pubmed">34458804</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalba J.M., Alca&#xed;n F.J. Sirtuin activators and inhibitors. Biofactors. 2012;38:349&#x2013;359. doi: 10.1002/biof.1032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1032</ArticleId><ArticleId IdType="pmc">PMC3467333</ArticleId><ArticleId IdType="pubmed">22730114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Yang Y., Gao Y., Wang Z., Ma J. Melatonin Attenuates Anoxia/Reoxygenation Injury by Inhibiting Excessive Mitophagy through the MT2/SIRT3/FoxO3a Signaling Pathway in H9c2 Cells. Drug Des. Dev. 2020;14:2047&#x2013;2060. doi: 10.2147/DDDT.S248628.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S248628</ArticleId><ArticleId IdType="pmc">PMC7260543</ArticleId><ArticleId IdType="pubmed">32546969</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Xiang H., Liu J., Chen Y., He R.R., Liu B. Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target. Theranostics. 2020;10:8315&#x2013;8342. doi: 10.7150/thno.45922.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.45922</ArticleId><ArticleId IdType="pmc">PMC7381741</ArticleId><ArticleId IdType="pubmed">32724473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovechkin A.V., Tyagi N., Sen U., Lominadze D., Steed M.M., Moshal K.S., Tyagi S.C. 3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006;291:L905&#x2013;L911. doi: 10.1152/ajplung.00543.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00543.2005</ArticleId><ArticleId IdType="pmc">PMC3182487</ArticleId><ArticleId IdType="pubmed">16815886</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder A., Behera J., Jeremic N., Tyagi S.C. Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy. J. Cell. Biochem. 2017;118:2108&#x2013;2117. doi: 10.1002/jcb.25841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.25841</ArticleId><ArticleId IdType="pmc">PMC6563903</ArticleId><ArticleId IdType="pubmed">27982479</ArticleId></ArticleIdList></Reference><Reference><Citation>Steed M.M., Tyagi N., Sen U., Schuschke D.A., Joshua I.G., Tyagi S.C. Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010;299:L301&#x2013;L311. doi: 10.1152/ajplung.00065.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00065.2010</ArticleId><ArticleId IdType="pmc">PMC2951073</ArticleId><ArticleId IdType="pubmed">20581102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood H.S., Cox M.J., Tyagi S.C. Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats. Antioxid. Redox Signal. 2002;4:799&#x2013;804. doi: 10.1089/152308602760598954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/152308602760598954</ArticleId><ArticleId IdType="pubmed">12470508</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang F., Giordano C., Shang D., Li Q., Petrof B.J. The dual CCR2/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmdmdx-4Cv) mice. PLoS ONE. 2018;13:e0194421. doi: 10.1371/journal.pone.0194421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0194421</ArticleId><ArticleId IdType="pmc">PMC5862483</ArticleId><ArticleId IdType="pubmed">29561896</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Baalachandran R., Li Y., Zhang C.O., Ke Y., Karki P., Birukov K.G., Birukova A.A. Circulating extracellular histones exacerbate acute lung injury by augmenting pulmonary endothelial dysfunction via TLR4-dependent mechanism. Am. J. Physiol. Lung Cell. Mol. Physiol. 2022;323:L223&#x2013;L239. doi: 10.1152/ajplung.00072.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00072.2022</ArticleId><ArticleId IdType="pmc">PMC9512107</ArticleId><ArticleId IdType="pubmed">35852995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai S., Li Q., Ding J., Liang F., Gusev E., Lapohos O., Fonseca G.J., Kaufmann E., Divangahi M., Petrof B.J. TLR4 is a regulator of trained immunity in a murine model of Duchenne muscular dystrophy. Nat. Commun. 2022;13:879. doi: 10.1038/s41467-022-28531-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28531-1</ArticleId><ArticleId IdType="pmc">PMC8847425</ArticleId><ArticleId IdType="pubmed">35169163</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenichel G.M., Florence J.M., Pestronk A., Mendell J.R., Moxley R.T., 3rd, Griggs R.C., Brooke M.H., Miller J.P., Robison J., King W., et al. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology. 1991;41:1874&#x2013;1877. doi: 10.1212/WNL.41.12.1874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.41.12.1874</ArticleId><ArticleId IdType="pubmed">1745340</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciafaloni E., Moxley R.T. Treatment options for Duchenne muscular dystrophy. Curr. Treat. Opt. Neurol. 2008;10:86&#x2013;93. doi: 10.1007/s11940-008-0010-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11940-008-0010-4</ArticleId><ArticleId IdType="pubmed">18334131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricotti V., Ridout D.A., Pane M., Main M., Mayhew A., Mercuri E., Manzur A.Y., Muntoni F. The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: Considerations for the design of clinical trials. J. Neurol. Neurosurg. Psychiatry. 2016;87:149&#x2013;155. doi: 10.1136/jnnp-2014-309405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309405</ArticleId><ArticleId IdType="pmc">PMC4752678</ArticleId><ArticleId IdType="pubmed">25733532</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissel J.T., Burrow K.L., Rammohan K.W., Mendell J.R. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group. Neurology. 1991;41:667&#x2013;672. doi: 10.1212/WNL.41.5.667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.41.5.667</ArticleId><ArticleId IdType="pubmed">2027481</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanigan K.M., Campbell K., Viollet L., Wang W., Gomez A.M., Walker C.M., Mendell J.R. Anti-dystrophin T cell responses in Duchenne muscular dystrophy: Prevalence and a glucocorticoid treatment effect. Hum. Gene Ther. 2013;24:797&#x2013;806. doi: 10.1089/hum.2013.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2013.092</ArticleId><ArticleId IdType="pmc">PMC3768239</ArticleId><ArticleId IdType="pubmed">24010700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Du Y., Guo Y., Wang Z., Li H., Lv Z., Zeng L., Chen Y., Xie Z., Li R. TLR4-NLRP3-GSDMD-Mediated Pyroptosis Plays an Important Role in Aggravated Liver Injury of CD38-/- Sepsis Mice. J. Immunol. Res. 2021;2021:6687555. doi: 10.1155/2021/6687555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6687555</ArticleId><ArticleId IdType="pmc">PMC8026301</ArticleId><ArticleId IdType="pubmed">33860064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zhu X., Yuan S., Wen S., Liu X., Wang C., Qu Z., Li J., Liu H., Sun L., et al. TLR4/NF-&#x3ba;B Signaling Induces GSDMD-Related Pyroptosis in Tubular Cells in Diabetic Kidney Disease. Front. Endocrinol. 2019;10:603. doi: 10.3389/fendo.2019.00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2019.00603</ArticleId><ArticleId IdType="pmc">PMC6761221</ArticleId><ArticleId IdType="pubmed">31608008</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Zhao Y., Wang K., Shi X., Wang Y., Huang H., Zhuang Y., Cai T., Wang F., Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660&#x2013;665. doi: 10.1038/nature15514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15514</ArticleId><ArticleId IdType="pubmed">26375003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal B., Serrano A.L., Tjwa M., Suelves M., Ardite E., De Mori R., Baeza-Raja B., Mart&#xed;nez de Lagr&#xe1;n M., Lafuste P., Ruiz-Bonilla V., et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev. 2008;22:1747&#x2013;1752. doi: 10.1101/gad.465908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.465908</ArticleId><ArticleId IdType="pmc">PMC2492661</ArticleId><ArticleId IdType="pubmed">18593877</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin L.E., Williams J.E., Deering M., Brazeau D., Koury S., Martinez D.A. Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle. Muscle Nerve. 2004;30:645&#x2013;653. doi: 10.1002/mus.20150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20150</ArticleId><ArticleId IdType="pubmed">15389721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahani R., Wallace C.H., Jones B.K., Blemker S.S. Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne muscular dystrophy. J. Appl. Physiol. (Bethesda Md. 1985) 2022;132:653&#x2013;672. doi: 10.1152/japplphysiol.00248.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00248.2021</ArticleId><ArticleId IdType="pmc">PMC9076426</ArticleId><ArticleId IdType="pubmed">35050792</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., Pushpakumar S., Zheng Y., Homme R.P., Smolenkova I., Mokshagundam S.P.L., Tyagi S.C. Hydrogen sulfide mitigates skeletal muscle mitophagy-led tissue remodeling via epigenetic regulation of the gene writer and eraser function. Physiol. Rep. 2022;10:e15422. doi: 10.14814/phy2.15422.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.15422</ArticleId><ArticleId IdType="pmc">PMC9391604</ArticleId><ArticleId IdType="pubmed">35986494</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi S.C., Stanisic D., Singh M. Epigenetic memory: Gene writer, eraser and homocysteine. Mol. Cell. Biochem. 2021;476:507&#x2013;512. doi: 10.1007/s11010-020-03895-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-020-03895-4</ArticleId><ArticleId IdType="pubmed">33030620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sbodio J.I., Snyder S.H., Paul B.D. Regulators of the transsulfuration pathway. Br. J. Pharmacol. 2019;176:583&#x2013;593. doi: 10.1111/bph.14446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14446</ArticleId><ArticleId IdType="pmc">PMC6346075</ArticleId><ArticleId IdType="pubmed">30007014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluijtmans L.A., Boers G.H., Stevens E.M., Renier W.O., Kraus J.P., Trijbels F.J., van den Heuvel L.P., Blom H.J. Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J. Clin. Investig. 1996;98:285&#x2013;289. doi: 10.1172/JCI118791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118791</ArticleId><ArticleId IdType="pmc">PMC507429</ArticleId><ArticleId IdType="pubmed">8755636</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Tian Y.J., Guo J., Sun W.P., Lun Y.Z., Guo M., Luo N., Cao Y., Cao J.M., Gong X.J., et al. Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats. Br. J. Nutr. 2013;110:2156&#x2013;2164. doi: 10.1017/S0007114513001815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114513001815</ArticleId><ArticleId IdType="pubmed">23768418</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., Hardin S.J., George A.K., Eyob W., Stanisic D., Pushpakumar S., Tyagi S.C. Epigenetics, 1-Carbon Metabolism, and Homocysteine during Dysbiosis. Front. Physiol. 2020;11:617953. doi: 10.3389/fphys.2020.617953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.617953</ArticleId><ArticleId IdType="pmc">PMC7940193</ArticleId><ArticleId IdType="pubmed">33708132</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>